Drug profile

The FDA adverse-event record for Blood Plasma

18 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Blood Plasma. See the species affected, top reactions, and outcomes below.

18
adverse-event reports
50.0%
death-coded share
Dog
most-reported species
7
Tachycardia - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
18
Total Reports
9
Deaths Reported
50.0%
Death Rate

Active Ingredients

Blood Plasma

Administration Routes

UnknownParenteralIntravenousOral

Species Affected

Dog 15
Pig 2
Cat 1

Most Affected Breeds

Retriever - Labrador 6
Rottweiler 2
Terrier - West Highland White 1
Domestic Shorthair 1
Catahoula Leopard Dog 1
Pig (unknown) 1
Siberian Husky 1
Bulldog - American 1
Bulldog - English 1
Crossbred Porcine/Pig 1

Most Reported Reactions

Tachycardia 7
Low platelet count 6
Elevated alanine aminotransferase (ALT) 6
Other abnormal test result NOS 6
Death 6
Weak pulse 6
Hypoglycaemia 6
Diarrhoea 5
Elevated total bilirubin 5
Hyperglycaemia 5
Pale mucous membrane 5
Lethargy (see also Central nervous system depression in Neurological) 5

Outcome Breakdown

Outcome Unknown
6 (31.6%)
Died
6 (31.6%)
Euthanized
4 (21.1%)
Ongoing
2 (10.5%)
Recovered/Normal
1 (5.3%)

Blood Plasma Adverse Event Insights

18 reports name Blood Plasma; 9 recorded a death outcome (50.0% of reported events, not a population-level mortality rate). Active ingredient: Blood Plasma. Administration routes: Unknown, Parenteral, Intravenous, Oral.

By species: Dog (15 reports), Pig (2 reports), Cat (1 reports). By breed: Retriever - Labrador (6), Rottweiler (2), Terrier - West Highland White (1).

Leading clinical signs: Tachycardia (7), Low platelet count (6), Elevated alanine aminotransferase (ALT) (6), Other abnormal test result NOS (6). Outcome, 19 coded reports: Outcome Unknown leads at 31.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.